Skip to main content

India’s National Medical Device Policy 2023 positions the nation to be a global leader in medical device manufacturing and innovation. The policy sets a roadmap for India to gain a 10-12% share in the global market over 25 years by focusing on regulatory mechanisms, infrastructure development, research and investment, human resource development, and market positioning. Key initiatives include a “Single Window Clearance System” for licensing, fostering academic-industry collaboration, promoting investment, establishing medical device parks, and developing a skilled workforce. The policy aims to improve India’s healthcare landscape and make quality healthcare products accessible.

India, with its ambitious National Medical Device Policy 2023, is poised to become a global leader in the manufacturing and innovation of medical devices. This forward-thinking policy sets out a comprehensive roadmap to achieve a 10-12% share in the expanding global market over the next 25 years. By focusing on regulatory mechanisms, infrastructure development, research and development, investment, human resource development, and positioning, this policy aims to transform India’s healthcare landscape and improve healthcare outcomes for its citizens.

One of the key highlights of the policy is the establishment of a “Single Window Clearance System” for licensing medical devices. This mechanism will streamline the regulatory process, preventing duplication of work and reducing compliance burdens. By aligning the pricing regulation framework with the provisions of the Drugs (Prices Control) Order (DPCO), 2013, through the National Pharmaceutical Pricing Authority (NPPA), the policy ensures affordable access to high-quality healthcare products for all.

To encourage innovation and research, the policy emphasizes the need for collaboration between academic institutions and industry. Joint research and development projects and the establishment of Centers of Excellence in premier institutions will foster a culture of innovation and enable India to develop innovative medical technologies. Furthermore, the policy recognizes the importance of investment in the sector. It promotes seed capital and funding from venture capitalists, inviting them to actively engage in incubating start-ups and supporting private investments. New financing models, such as blended finance, will also be explored to attract both public and private funds.

The policy recognizes that a robust healthcare infrastructure is vital for the growth of the medical device sector. It proposes the establishment and strengthening of large medical device parks and clusters in proximity to economic zones, ensuring easy logistics connectivity. Additionally, testing and certification facilities in government institutions will enhance the quality assurance process. The policy also emphasizes the importance of an uninterrupted supply chain, ensuring continuous access to medical devices, which will boost domestic manufacturing capabilities.

Human resource development is another crucial aspect of the policy. By supporting multidisciplinary courses in medical devices and creating a national database of required skills, the policy aims to build a skilled workforce that can meet the demands of the rapidly evolving MedTech sector. This focus on skill development will not only generate employment opportunities but also enhance India’s manufacturing competitiveness.

Positioning India as an attractive destination for medical device manufacturing and innovation is another key objective of the policy. It advocates the creation of a resolute export promotion council to address market access issues. By promoting awareness of medical device safety standards and communicating the value proposition to the public, the policy seeks to build trust and confidence in domestically manufactured medical devices. It also encourages learning from successful manufacturing and skilling systems around the world and exploring the possibility of implementing similar models in India.

To ensure effective implementation and monitoring, the policy envisions close coordination with NITI Aayog. Quantitative metrics will be developed to assess equitable access to affordable medical devices, manufacturing independence, improvement in the healthcare index, reduced disease burden, and the creation of high-value jobs. Regular monitoring of economic indicators, such as exports, export volumes, and foreign direct investments, will provide insights into the sector’s growth and performance.

The National Medical Device Policy 2023 lays the groundwork for India’s transformation into a global hub for medical device manufacturing and innovation. By prioritizing regulatory efficiency, infrastructure development, research and development, investment, human resource development, and positioning, the policy demonstrates India’s commitment to improving healthcare outcomes and ensuring access to affordable, high-quality medical devices. As the policy is implemented and progresses, India has the potential to revolutionize healthcare not only within its borders but also on a global scale.

InnoHEALTH magazine digital team

Author InnoHEALTH magazine digital team

More posts by InnoHEALTH magazine digital team

Leave a Reply